Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 193-201

  Culmsee, Carsten ^a   Junker, Vera ^a   Wolz, Philipp ^a   Semkova, Irina ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cerebral ischemia; Excitotoxicity; Glutamate; Hippocampal cells; Lubeluzole; Middle cerebral artery occlusion

Indexed keywords

GLUTAMIC ACID; LUBELUZOLE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN ISCHEMIA; CELLS, CULTURED; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PIPERIDINES; RATS; RATS, INBRED F344; STEREOISOMERISM; THIAZOLES;

EID: 0032567809     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01499-4     Document Type: Article

References (25)

1. Aronowski J., Strong R., Grotta J.C. Combined neuroprotection and reperfusion therapy for stroke: Effect of lubeluzole and diasperin cross-linked hemoglobin in experimental focal ischemia. Stroke. 27:1996;1571-1576.
2. Aronowski J., Strong R., Grotta J.C. Treatment of experimental focal ischemia in rats with lubeluzole. Neuropharmacology. 35:1996;689-693.
3. Backhauß C., Karkoutly C., Welsch M., Krieglstein J. A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmacol. Methods. 27:1992;23-27.
4. De Ryck M., Keersmakers R., Clincke G., Jannsen M., Van Reet S. Lubeluzole a novel benzothiazole, protects neurological function after cerebral thrombotic stroke in rats: An apparent stereospecific effect. Soc. Neurosci. Abstr. 20:1994;185.
5. De Ryck M., De Prins E., Nolten C., Marrannes R., Clincke G. Lubeluzole improves penumbra measured by cortical spreading depression in rats. Soc. Neurosci. Abstr. 21:1995;1031.
6. De Ryck M., Keersmakers R., Duytschaever H., Claes C., Clincke G., Jannsen M., Van Reet S. Lubeluzole protects sensimotor function and reduces infarct size in a photochemical stroke model in rats. JPET. 279:1996;748-758.
7. Diener H.C., Hacke W., Hennerici M., Radberg J., Hantson L., De Keyser J. Lubeluzole in acute ischemic stroke: A double blind, placebo-controlled phase II trial. Stroke. 27:1996;76-81.
8. Du C., Hu R., Csernansky C.A., Hsu C.Y., Choi D.W. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J. Cereb. Blood Flow Metab. 16:1995;195-201.
9. Greenamyre J.T., Young A.B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging. 10:1989;605-606.
10. Koh J.I., Choi D.W. Vulnerability of cultured cortical neurons to damage by excitotoxins: Differential susceptibility of neurons containing NADPH-diaphorase. J. Neurosci. 8:1988;2153-2163.
11. Krieglstein, J., 1996. Pharmacology of Cerebral Ischemia 1996. Medpharm Scientific Publishers, Stuttgart.
12. Krieglstein, J., Oberpichler-Schwenk, H., 1994. Pharmacology of Cerebral Ischemia 1994. Medpharm Scientific Publishers, Stuttgart.
13. Lees G., Anzal M. Stroke and cerebral ischemia: Perspectives for clinical treatment and new drugs based on molecular pathophysiology. Pharm. J. 2:1996;269-275.
14. Lesage A.S., De Loore K.L., Osikowska-Evers B., Peeters L., Leysen J.E. Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NO-synthase pathway. Soc. Neurosci. Abstr. 20:1994;185.
15. Lesage A.S., Peeters L., Leysen J.E. Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. JPET. 279:1996;759-766.
16. Linnik M.D., Zobrist R.H., Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2009.
17. Marshall R.S., Mohr J.P. Current management of ischemic stroke. J. Neurol. Surg. Psychol. 56:1993;6-16.
18. Maiese K., TenBroeke M., Kue I. Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J. Neurochem. 68:1997;710-714.
19. Olney J.W., Zorumski C.F., Price M.T., Wang G.G., Labryere J. Excitotoxicity of L-DOPA and 6-OH-DPAT: Implications for Parkinson's and Huntington's diseases. Exp. Neurol. 108:1990;269-272.
20. O'Neill M., Allain F., Bentué-Ferrer D., Bellissant M., de Certaines J., Leonard B.E. Pharmacological strategies in the treatment of cerebral ischemia. Eur. Neurol. 35 (Suppl. 1):1995;28-36.
21. Scheller D., Kolb J., Szathmary S., Zacharias E., De Ryck M., Van Reempts J., Clincke B., Tegtmeier F. Extracellular changes of glutamate in the periinfarct zone: Effect of lubeluzole. J. Cereb. Blood Flow Metab. 15 (Suppl. 1):1995;379.
22. Semkova I., Wolz P., Schilling M., Krieglstein J. Selegeline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur. J. Pharmacol. 315:1996;19-30.
23. Simon R.P., Swans J.H., Griffith T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
24. Tamura A., Graham D.J., McCulloch J., Taesdale G.M. Focal cerebral ischemia in the rat: 1. Description of the technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
25. Welsh F.A., Sakamoto T., McKee A.E., Sims R.E. Effect of lactatacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem. 49:1987;846-851.